We are pleased to invite you to the webinar titled ‘Treat Psoriasis for the Long Haul: Findings from Clinical Trials and Real-World Evidence ’ presented by Dr. Sandy McBride and Prof. Luis Sanz
• How moderate-to-severe plaque psoriasis affects patients’ quality of life
• Recent data on ixekizumab’s (Taltz®) sustained efficacy up to 5 years and PASI100 results from head-to-head trials
• Real-world evidence to better understand the long-term effectiveness and safety of biologics
Director, Department of Dermatology.
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Royal Free Hospital, London